2004年至2013年美国产褥期子宫内翻的风险与后果
基于美国全国住院患者样本2004至2013年8,294,279例分娩,识别2,427例子宫内翻,发生率为每万次分娩2.9例(95%CI 2.8-3.0),研究期间发生率无变化。队列中1例孕产妇死亡(每万例事件4.1例),37.7%合并产后出血,22.4%接受输血,6.0%需手术处理,仅2.8%行子宫切除术,中位住院3天。
要点
- 子宫内翻发生率为每万次分娩2.9例(95%CI 2.8-3.0),研究期间无变化。
- 合并产后出血占37.7%,接受输血占22.4%,需手术处理占6.0%。
- 子宫切除术仅占2.8%,中位住院时间为3天。
核心结论
- 本研究提供了迄今最大规模的产褥期子宫内翻人群-based结果,强调该病与不良孕产妇结局的高可能性。
- 结果有助于优化临床管理,为罕见子宫内翻时可能出现的产后出血、血制品需求和手术处理做好准备。
研究设计与样本
- 使用美国全国住院患者样本(Nationwide Inpatient Sample,美国住院病例的20%样本),识别2004年至2013年所有分娩。
- 采用国际疾病分类第九版诊断代码识别子宫内翻病例及相关不良结局(孕产妇死亡、输血、孕产妇休克、需手术矫正、住院时间)。
主要发现
- 2004年至2013年8,294,279例分娩中,有2,427例子宫内翻,发生率为每万次分娩2.9例(95%CI 2.8-3.0)。
- 队列中1例孕产妇死亡(每万例事件4.1例)。
- 研究期间未检测到子宫内翻发生率的变化。
- 子宫内翻女性中,37.7%(95%CI 35.8-39.6%)合并产后出血,22.4%(95%CI 20.7-24.0%)接受输血,6.0%(95%CI 5.1-7.0%)需手术处理。
- 仅2.8%(95%CI 2.1-3.5%)行子宫切除术;中位住院时间为3天。
临床怎么用
- 原文结论指出结果有助于优化临床管理,为罕见子宫内翻时可能出现的产后出血、血制品需求和手术处理做好准备。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Puerperal uterine inversion is a rare, potentially life-threatening obstetrical emergency. The current literature consists of small case series and a single nationwide study from Europe with only 15 cases. OBJECTIVE: We aimed to define the incidence, temporal trends, and outcomes in women with uterine inversion using a nationally representative US cohort. STUDY DESIGN: We used the Nationwide Inpatient Sample, a 20% sample of US hospital admissions, to identify all deliveries from 2004 through 2013. International Classification of Diseases, Ninth Revision diagnosis codes were used to identify cases of uterine inversion and associated adverse outcomes (maternal death, blood transfusion, maternal shock, need for surgical correction, and length of hospital stay). The incidence of uterine inversion overall and for each year of the study period was calculated with 95% confidence intervals. The case fatality and incidence of other adverse outcomes among women with a uterine inversion were also estimated. RESULTS: Among 8,294,279 deliveries in 2004 through 2013, there were 2427 cases of puerperal uterine inversion, corresponding to an incidence of 2.9 per 10,000 deliveries (95% confidence interval, 2.8-3.0). There was 1 maternal death in our cohort (4.1 per 10,000 events). No change in the incidence of uterine inversion over the study period was detected. Among women with a uterine inversion, 37.7% (95% confidence interval, 35.8-39.6%) had an associated postpartum hemorrhage, 22.4% (95% confidence interval, 20.7-24.0%) received a blood transfusion, and 6.0% (95% confidence interval, 5.1-7.0%) required surgical management. Only 2.8% (95% confidence interval, 2.1-3.5%) underwent a hysterectomy. The median length of hospital stay was 3 days. CONCLUSION: This study provides the largest population-based results on puerperal uterine inversion to date and highlights the high likelihood of adverse maternal outcomes associated with the condition. The results inform the optimization of clinical management, by preparing for possible postpartum hemorrhage, need for blood products, and surgical management in the rare event of uterine inversion.
引用
- Coad SL, Dahlgren LS, Hutcheon JA, et al. Risks and consequences of puerperal uterine inversion in the United States, 2004 through 2013. Am J Obstet Gynecol. 2017. PMID: 28522320. doi:10.1016/j.ajog.2017.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。